DSGN
Design Therapeutics Inc
12.30$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -78.2% | -35.5% | +65.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +181.4% | +80.4% | +41.5% | -99.9% | +200.0% | +158.3% | +164.5% | +17.1% | +17.7% | +8.0% | +10.7% | +3.0% | +2.9% | -4.2% | +0.7% | +3.6% | +5.6% | +1.3% | -2.6% | +6.7% | -4.4% | +9,498.0% | -201.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -154.1% | – | – | – | – | – | – | |
| – | +181.4% | +80.4% | +41.5% | +43.1% | +29.7% | +69.9% | -14.1% | +19.4% | +29.0% | +26.6% | -0.3% | +10.3% | +8.5% | -22.3% | -16.9% | -12.3% | +7.3% | +14.6% | +2.4% | +26.5% | +2.3% | -7.3% | -8.0% | +7.1% | +14.0% | – | |
| – | +11.6% | +12.9% | +142.5% | +52.2% | +47.4% | +5.2% | +35.5% | +21.7% | -5.8% | +12.5% | +5.1% | +15.3% | -6.6% | +0.6% | -26.2% | +11.9% | -3.2% | -1.8% | +3.8% | +11.1% | +15.7% | -20.2% | +3.5% | +10.7% | +8.7% | – | |
| – | +134.8% | +62.9% | +62.0% | +47.1% | +35.3% | +47.5% | -1.9% | +20.2% | +17.0% | +22.7% | +1.0% | +11.6% | +4.4% | -17.3% | -19.1% | -5.7% | +4.5% | +9.1% | +2.8% | +22.3% | +4.9% | -78.0% | +597.0% | -40.1% | +11.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +69.4% | +509.5% | +132.5% | +46.2% | -94.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,355.2% | – | -96.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.